CDR-Life announces early clinical data demonstrating pharmacodynamic activity of CDR404: Zurich, Switzerland Saturday, October 25, 2025, 18:00 Hrs [IST] CDR-Life, Inc, a biotechno ...
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...
Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. For eligible patients, liver surgery or hepatectomy is an effective treatment option. However, ...
Takeda ( TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent Biologics (HKEX: 01801) for the development, manufacturing and ...
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies.
The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback